NEW YORK (360Dx) – The US Food and Drug Administration said today that Laboratory Corporation of America reported false-positive results using the first commercially available Zika serological IgM test, which is manufactured by InBios International.

As a result, the FDA issued recommendations to physicians using the test not to depend solely on it to diagnose patients.